Skip to main content

Table 2 Genotypes’ and alleles’ frequencies of 7 assessed polymorphisms in 100 cervix carcinoma patients in addition to 100 age-and-gender matched control volunteers without cancers

From: HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia

Gene, genotype and allele

Cancer patients’ frequency

Normal volunteers’ frequency

Odds ratio

P- Value

(95% CI)

 

(%, n= 100)

(%, n= 100)

CDKN1A (p21) codon 31 C>A Ser/Arg rs1801270

C/C

64 (64)

62 (62)

  

C/A

32 (32)

35 (35)

0.89 (0.49-1.60)

0.69

A/A

4 (4)

3 (3)

1.29 (0.28-6.01)

0.74

C

160 (80)

159 (79)

  

A

40 (20)

41 (21)

0.97 (0.59-1.58)

0.90

TP53 (p53) codon 72 G>C Arg/Pro rs1042522

G/G

20 (20)

22 (22)

  

G/C

58 (58)

52 (52)

1.23 (0.60-2.50)

0.57

C/C

22 (22)

26 (26)

0.93 (0.41-2.14)

0.87

G

98 (49)

96 (48)

  

C

102 (51)

104 (52)

0.96 (0.65-1.42)

0.84

ATM codon 1853 G>A Asp/Asn rs1801516

G/G

90 (90)

88 (88)

  

G/A

8 (8)

12 (12)

0.65 (0.25-1.67)

0.37

A/A

2 (2)

0 (0)

4.89 (0.23-103.2)

0.16

G

188 (94)

188 (94)

  

A

12 (6)

12 (6)

1.00 (0.44-2.28)

1

HDM2 promoter 309 T>C rs2279744

T/T

30 (30)

27 (27)

  

T/C

46 (46)

44 (44)

0.94 (0.48-1.83)

0.86

C/C

24 (24)

29 (29)

0.75 (0.35-1.58)

0.44

T

106 (53)

98 (49)

  

C

94 (47)

102 (51)

0.85 (0.58-126)

0.42

TGFβ1 codon 10 T>C Leu/Pro rs1982073

T/T

48 (48)

39 (39)

  

T/C

31 (31)

38 (38)

0.89 (0.42-1.91)

0.77

C/C

21 (21)

23 (23)

1.35 (0.65-2.79)

0.42

T

127 (64)

116 (58)

  

C

73 (37)

84 (42)

1.26 (0.84-1.88)

0.26

XRCC1 codon 399 G>A Arg/Gln rs25487

G/G

52 (52)

59 (59)

  

G/A

34 (34)

40 (40)

0.96 (0.54-1.74)

0.90

A/A

14 (14)

1 (1)

15.88 (2.0-124.9))

0.0007

G

138 (69)

158 (79)

  

A

62 (31)

42 (21)

1.69 (1.07-2.66)

0.02

XRCC3 codon 241 C>T Thr/Met rs861539

C/C

45 (45)

41 (41)

  

C/T

44 (44)

37 (37)

1.08 (0.59-1.99)

0.79

T/T

11 (11)

22 (22)

0.46 (0.20-1.05)

0.06

C

134 (67)

119 (60)

  

T

66 (33)

81 (41)

0.72 (0.48-1.09)

0.12